
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
Live life on your toes, not your heels, says Lynn O’Connor Vos, CEO of Grey Healthcare Group. Each day offers a new opportunity to invest in the way the industry communicates—and reinvent the way people think. Of course you’ll grow the business. Along the way, don’t forget to grow yourself.






